Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial

Peer Review reports

Original Submission
9 Jun 2017	Submitted	Original manuscript
8 Aug 2017	Reviewed	Reviewer Report - Nobuhiro Ooba
9 Aug 2017	Reviewed	Reviewer Report - Dimitris tousoulis
16 Aug 2017	Reviewed	Reviewer Report - Cyril Mamotte
21 Sep 2017	Author responded	Author comments - Jun-Bean Park
Resubmission - Version 2
21 Sep 2017	Submitted	Manuscript version 2
Publishing
3 Oct 2017	Editorially accepted
27 Oct 2017	Article published	10.1186/s13063-017-2229-4

Back to article page